Search Results - "Williams, Naomi J."

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer by Hamdy, Freddie C., Donovan, Jenny L., Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Turner, Emma L., Martin, Richard M., Young, Grace J., Walsh, Eleanor I., Bryant, Richard J., Bollina, Prasad, Doble, Andrew, Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Powell, Philip, Rosario, Derek J., Rowe, Edward, Mason, Malcolm, Catto, James W.F., Peters, Tim J., Oxley, Jon, Williams, Naomi J., Staffurth, John, Neal, David E.

“…In men with prostate cancer on PSA screening, radical treatments led to half the incidence of metastasis and local progression as active monitoring without…”
Get full text

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial by Martin, Richard M, Donovan, Jenny L, Turner, Emma L, Metcalfe, Chris, Young, Grace J, Walsh, Eleanor I, Lane, J. Athene, Noble, Sian, Oliver, Steven E, Evans, Simon, Sterne, Jonathan A. C, Holding, Peter, Ben-Shlomo, Yoav, Brindle, Peter, Williams, Naomi J, Hill, Elizabeth M, Ng, Siaw Yein, Toole, Jessica, Tazewell, Marta K, Hughes, Laura J, Davies, Charlotte F, Thorn, Joanna C, Down, Elizabeth, Davey Smith, George, Neal, David E, Hamdy, Freddie C

“…IMPORTANCE: Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from…”
Get full text

MicroRNA-146a regulates ICOS–ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres by Pratama, Alvin, Srivastava, Monika, Williams, Naomi J., Papa, Ilenia, Lee, Sau K., Dinh, Xuyen T., Hutloff, Andreas, Jordan, Margaret A., Zhao, Jimmy L., Casellas, Rafael, Athanasopoulos, Vicki, Vinuesa, Carola G.

“…Tight control of T follicular helper (Tfh) cells is required for optimal maturation of the germinal centre (GC) response. The molecular mechanisms controlling…”
Get full text

Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway by Lee, James C., Espéli, Marion, Anderson, Carl A., Linterman, Michelle A., Pocock, Joanna M., Williams, Naomi J., Roberts, Rebecca, Viatte, Sebastien, Fu, Bo, Peshu, Norbert, Hien, Tran Tinh, Phu, Nguyen Hoan, Wesley, Emma, Edwards, Cathryn, Ahmad, Tariq, Mansfield, John C., Gearry, Richard, Dunstan, Sarah, Williams, Thomas N., Barton, Anne, Vinuesa, Carola G., Phillips, Anne, Mowat, Craig, Drummond, Hazel, Kennedy, Nick, Lees, Charlie W., Satsangi, Jack, Taylor, Kirstin, Prescott, Natalie J., Mathew, Christopher G., Simpson, Peter, Simmons, Alison, Khan, Mohammed, Newman, William G., Hawkey, Christopher, Hart, Ailsa, Wilson, David C., Henderson, Paul, Barrett, Jeffrey C., Parkes, Miles, Lyons, Paul A., Smith, Kenneth G.C.

“…The clinical course and eventual outcome, or prognosis, of complex diseases varies enormously between affected individuals. This variability critically…”
Get full text

Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing by Jackson, Sherena D, de la Rue, May R, Greenslade, Thomas Pl, John, Anna M, Wahid, Shahida, Martin, Richard M, Williams, Naomi J, Turner, Emma L

“…To summarise and compare the key recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer, and so highlight where more evidence…”
Get more information

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee by Turner, Emma L, Metcalfe, Chris, Donovan, Jenny L, Noble, Sian, Sterne, Jonathan A C, Lane, J Athene, I Walsh, Eleanor, Hill, Elizabeth M, Down, Liz, Ben-Shlomo, Yoav, Oliver, Steven E, Evans, Simon, Brindle, Peter, Williams, Naomi J, Hughes, Laura J, Davies, Charlotte F, Ng, Siaw Yein, Neal, David E, Hamdy, Freddie C, Albertsen, Peter, Reid, Colette M, Oxley, Jon, McFarlane, John, Robinson, Mary C, Adolfsson, Jan, Zietman, Anthony, Baum, Michael, Koupparis, Anthony, Martin, Richard M

“…Background: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trials reporting prostate cancer-specific mortality outcomes…”
Get full text

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment by Donovan, Jenny L, Hamdy, Freddie C, Lane, J Athene, Young, Grace J, Metcalfe, Chris, Walsh, Eleanor I, Davis, Michael, Steuart-Feilding, Thomas, Blazeby, Jane M, Avery, Kerry N L, Martin, Richard M, Bollina, Prasad, Doble, Andrew, Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Powell, Phillip, Rosario, Derek J, Rowe, Edward, Mason, Malcolm, Catto, James W F, Peters, Tim J, Wade, Julia, Turner, Emma L, Williams, Naomi J, Oxley, Jon, Staffurth, John, Bryant, Richard J, Neal, David E

“…Outcomes after Localized Prostate Cancer TreatmentDonovan et al. present the long-term patient-reported outcomes of 1643 randomly assigned participants in the…”
Get more information

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer) by Williams, Naomi J, Hill, Elizabeth M, Ng, Siaw Yein, Martin, Richard M, Metcalfe, Chris, Donovan, Jenny L, Evans, Simon, Hughes, Laura J, Davies, Charlotte F, Hamdy, Freddie C, Neal, David E, Turner, Emma L

“…In cancer screening trials where the primary outcome is target cancer-specific mortality, the unbiased determination of underlying cause of death (UCD) is…”
Get full text

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality by Martin, RM, Turner, EL, Young, GJ, Metcalfe, C, Walsh, EI, Lane, JA, Sterne, JAC, Noble, S, Holding, P, Ben-Shlomo, Y

Get full text

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial by Martin, Richard M, Turner, Emma L, Young, Grace J, Metcalfe, Chris, Walsh, Eleanor I, Lane, J Athene, Sterne, Jonathan A C, Noble, Sian, Holding, Peter, Ben-Shlomo, Yoav, Williams, Naomi J, Pashayan, Nora, Bui, Mai Ngoc, Albertsen, Peter C, Seibert, Tyler M, Zietman, Anthony L, Oxley, Jon, Adolfsson, Jan, Mason, Malcolm D, Davey Smith, George, Neal, David E, Hamdy, Freddie C, Donovan, Jenny L

“…The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) reported no effect of prostate-specific antigen (PSA) screening on prostate cancer…”
Get full text

STRANGE TROUBLE by Williams, Naomi J.

Get full text